Financials
Income statement
Fiscal date | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
---|---|---|---|---|
Total reported revenue | 25.2B | 23.8B | 30.9B | 25.7B |
Cost of revenue | 17.9B | 17.1B | 22.9B | 18.4B |
Gross profit | 7.3B | 6.7B | 8.0B | 7.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 5.4B | 4.6B | 5.9B | 5.5B |
Other operating expenses | — | — | — | — |
Operating income | 1.3B | 1.5B | 1.5B | 1.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 116M | 116M | 90M | 105M |
Other income expense | 17M | 26M | 29M | 28M |
Pretax income | 1.2B | 1.4B | 1.4B | 1.1B |
Tax provision | 283M | 346M | 303M | 237M |
Net income | 935M | 1.0B | 1.1B | 854M |
Basic EPS | 2.1 | 2.3 | 2.4 | 1.9 |
Diluted EPS | 2.1 | 2.3 | 2.4 | 1.9 |
Basic average shares | 454.6M | 455M | 456.8M | 460.1M |
Diluted average shares | 455.6M | 456.5M | 458.4M | 461.5M |
EBITDA | 2.1B | 2.3B | 2.3B | 2.0B |
Net income from continuing op. | 935M | 1.0B | 1.1B | 854M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |